NCT04948333 2026-03-18Asciminib Treatment Optimization in ≥ 3rd Line CML-CPNovartisPhase 3 Completed199 enrolled 13 charts
NCT04015024 2019-07-16A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML PatientsCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 2 Unknown30 enrolled